Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GBIO |
---|---|---|
09:32 ET | 552 | 3.16 |
09:56 ET | 325 | 3.16 |
10:24 ET | 100 | 3.17 |
10:30 ET | 1000 | 3.22 |
10:35 ET | 1000 | 3.235 |
10:37 ET | 400 | 3.277 |
10:39 ET | 3100 | 3.24 |
10:42 ET | 100 | 3.24 |
10:51 ET | 306 | 3.24 |
11:00 ET | 1904 | 3.25 |
11:09 ET | 474 | 3.25 |
11:13 ET | 100 | 3.24 |
11:26 ET | 1000 | 3.25 |
11:27 ET | 625 | 3.26 |
11:29 ET | 100 | 3.24 |
11:31 ET | 470 | 3.2439 |
11:36 ET | 1249 | 3.2 |
11:38 ET | 100 | 3.22 |
11:40 ET | 3748 | 3.25 |
11:42 ET | 200 | 3.265 |
11:49 ET | 475 | 3.25 |
11:51 ET | 825 | 3.29 |
11:54 ET | 1100 | 3.29 |
12:03 ET | 2100 | 3.27 |
12:05 ET | 100 | 3.27 |
12:07 ET | 100 | 3.26 |
12:09 ET | 110 | 3.27 |
12:20 ET | 1646 | 3.29 |
12:30 ET | 2000 | 3.27 |
12:34 ET | 100 | 3.275 |
12:36 ET | 1039 | 3.3 |
12:45 ET | 100 | 3.3 |
12:48 ET | 774 | 3.27 |
12:56 ET | 2570 | 3.2577 |
12:57 ET | 1073 | 3.25 |
01:01 ET | 1430 | 3.2617 |
01:08 ET | 1496 | 3.276 |
01:10 ET | 2500 | 3.2767 |
01:12 ET | 1678 | 3.2459 |
01:14 ET | 554 | 3.24 |
01:42 ET | 883 | 3.245 |
01:44 ET | 500 | 3.245 |
01:51 ET | 663 | 3.21 |
02:02 ET | 200 | 3.21 |
02:09 ET | 400 | 3.215 |
02:24 ET | 150 | 3.22 |
02:36 ET | 100 | 3.22 |
02:44 ET | 954 | 3.22 |
02:45 ET | 1300 | 3.215 |
02:47 ET | 873 | 3.22 |
02:58 ET | 100 | 3.21 |
03:18 ET | 100 | 3.22 |
03:23 ET | 200 | 3.22 |
03:25 ET | 278 | 3.22 |
03:27 ET | 300 | 3.22 |
03:30 ET | 1760 | 3.215 |
03:34 ET | 100 | 3.21 |
03:36 ET | 100 | 3.22 |
03:50 ET | 400 | 3.23 |
03:54 ET | 200 | 3.25 |
03:56 ET | 540 | 3.25 |
03:57 ET | 2610 | 3.28 |
03:59 ET | 1400 | 3.29 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Generation Bio Co | 211.6M | -1.3x | --- |
Quantum-Si Inc | 215.6M | -2.4x | --- |
Prelude Therapeutics Inc | 211.5M | -2.0x | --- |
Ovid Therapeutics Inc | 217.1M | -4.3x | --- |
Lineage Cell Therapeutics Inc | 188.8M | -7.3x | --- |
Invivyd Inc | 219.5M | -0.9x | --- |
Generation Bio Co. is a biotechnology company. The Company is innovating non-viral genetic medicines to provide durable, redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The Company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet DNA (iqDNA) cargo produced by a scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis (RES). The Company is advancing a portfolio of programs guided by the potent and highly selective delivery of messenger ribonucleic acid (mRNA) and/or iqDNA using its ctLNP delivery system to target T cells, hematopoietic stem cells (HSCs), and hepatocytes, and intend to expand to additional tissues and cell types. Its work in T cells focuses on in vivo reprogramming of this cell type to treat cancer and autoimmune diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $211.6M |
---|---|
Revenue (TTM) | $10.0M |
Shares Outstanding | 66.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.87 |
EPS | $-2.56 |
Book Value | $3.07 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 21.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,820.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.